1. Home
  2. TMDX vs VTMX Comparison

TMDX vs VTMX Comparison

Compare TMDX & VTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • VTMX
  • Stock Information
  • Founded
  • TMDX 1998
  • VTMX 1998
  • Country
  • TMDX United States
  • VTMX Mexico
  • Employees
  • TMDX N/A
  • VTMX N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VTMX
  • Sector
  • TMDX Health Care
  • VTMX
  • Exchange
  • TMDX Nasdaq
  • VTMX Nasdaq
  • Market Cap
  • TMDX 2.3B
  • VTMX 2.3B
  • IPO Year
  • TMDX 2019
  • VTMX 2023
  • Fundamental
  • Price
  • TMDX $111.50
  • VTMX $27.82
  • Analyst Decision
  • TMDX Buy
  • VTMX Sell
  • Analyst Count
  • TMDX 10
  • VTMX 2
  • Target Price
  • TMDX $122.89
  • VTMX $27.50
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • VTMX 271.0K
  • Earning Date
  • TMDX 05-08-2025
  • VTMX 04-23-2025
  • Dividend Yield
  • TMDX N/A
  • VTMX 2.55%
  • EPS Growth
  • TMDX N/A
  • VTMX N/A
  • EPS
  • TMDX 1.41
  • VTMX 0.13
  • Revenue
  • TMDX $488,227,000.00
  • VTMX $258,927,122.00
  • Revenue This Year
  • TMDX $25.33
  • VTMX $18.81
  • Revenue Next Year
  • TMDX $20.53
  • VTMX $11.83
  • P/E Ratio
  • TMDX $79.36
  • VTMX $20.07
  • Revenue Growth
  • TMDX 64.43
  • VTMX 15.06
  • 52 Week Low
  • TMDX $55.00
  • VTMX $21.30
  • 52 Week High
  • TMDX $177.37
  • VTMX $37.92
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 78.52
  • VTMX 68.47
  • Support Level
  • TMDX $92.49
  • VTMX $27.05
  • Resistance Level
  • TMDX $95.71
  • VTMX $27.91
  • Average True Range (ATR)
  • TMDX 4.79
  • VTMX 0.84
  • MACD
  • TMDX 0.81
  • VTMX 0.11
  • Stochastic Oscillator
  • TMDX 71.36
  • VTMX 94.09

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About VTMX Corporacion Inmobiliaria Vesta S.A.B de C.V. each representing ten (10)

Corporacion Inmobiliaria Vesta SAB de CV is an internally managed real estate company that owns, manages, develops, and leases industrial properties in Mexico. The Company's primary business is the acquisition, development, and management of industrial and distribution center real estate. The company designs and constructs park-to-suit projects across various industries; undertakes build-to-suit projects; and provides site selection, design and engineering, and sale and leaseback services. The primary source of revenue is the rental income received from customers under operating leases. It serves aerospace, automotive, food and beverage, logistics, medical devices, plastics, and other industries.

Share on Social Networks: